首页> 美国卫生研究院文献>Clinical Medicine >COVID-19 viral expulsion through chest drains
【2h】

COVID-19 viral expulsion through chest drains

机译:Covid-19通过胸部排出的病毒驱逐

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Editor – We thank Akhtar et al for their very timely article on aerosol dissemination through a pleural drain bottle.1 We completely agree with their conclusion that further work in this field is required and would like to point out complementary work by Duffy et al which showed that aerosol emissions increased with increased air flow, with the largest increase observed in smaller particles (0.3–3 microns).2 A bubbling chest drain thus generates aerosols and a viral filter reduces the aerosols. Pleural fluid has been shown to be positive for SARS-CoV-2 in a post-mortem series and data are lacking from the cases but it seems effusions developed due to other causes rather than the viral infection.3 The above evidence is currently reflected in the British Thoracic Society that bubbling drains in patients should have droplet exposure minimised by connecting any chest drain to wall suction to create a closed system, applying the described filter or using a digital suction device.4 The Acute Care Surgery and Critical Care Committees have produced a clear algorithm for chest drain insertion and there is now enough evidence for this to be widely implemented.5 Locally, this has been adopted with the emergency team only performing chest drains in the department for emergency cases (trauma or tension pneumothorax) and that patients are being moved to a respiratory ward to wait for their SARS-CoV-2 swab to be available before a chest drain is performed. Our current time for a swab is approximately 4 hours (45 minutes for a fast-track swab) and so far, there has been no excess mortality or morbidity to waiting for a swab result. We have plans in place to perform therapeutic aspirations if a procedure is required for symptom relief if the patient cannot wait.
机译:编辑 - 我们感谢Akhtar等,通过胸腔排水瓶来说,他们非常及时地进行气溶胶传播.1我们完全同意他们的结论,即在这一领域进一步工作,并希望通过Duffy等人指出气溶胶排放随着空气流量的增加而增加,在较小的颗粒(0.3-3微米)中观察到的最大增加胸腔流体已被证明是验尸后系列中的SARS-COV-2阳性,并且数据缺乏案例,但它似乎由于其他原因而不是病毒感染而产生的积液.3上述证据目前反映在血液胸部社会认为患者的血液漏洞应通过将任何胸部排水管连接到壁吸入来产生闭合系统,以产生封闭的系统,应用所述过滤器或使用数字吸力装置.4急性护理手术和关键护理委员会产生了胸部排水装置的清晰算法,现在有足够的证据是在本地被广泛实施的.5,这是通过急诊团队采用的,仅在急诊病例(创伤或张力气胸)和患者中进行胸部排水管在进行胸部排水之前,正在移动到呼吸道等待他们的SARS-COV-2拭子。我们的当前拭子的时间约为4小时(快速轨道拭子45分钟),到目前为止,没有过多的死亡率或发病率来等待拭子结果。如果患者不能等待,我们有计划进行治疗愿望,如果症状缓解症状缓解。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号